Intellia's Crispr Gene Editing Treatment Succeeds in Phase 3 Trial
Intellia Therapeutics, building exterior and company sign, Cambridge, Massachusetts, United States. Spencer Scholarship | Universal Image Group | fake images…
Biotechnology and pharmaceuticals
Novartis, Amgen and Eli Lilly's Lp(a) Drugs Aim to Prevent Heart Attacks
Pharma believes it has found the next frontier in heart attack prevention. Novartis, amgen and Eli Lilly are among drugmakers…
Regeneron signs drug pricing deal with Trump, will offer free hearing loss therapy
Regeneron He agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump,…
Regeneron weighs overseas pricing of gene therapy for rare hearing loss
Regeneron Pharmaceuticals will make its recently approved gene therapy for a rare genetic form of hearing loss available for free…
FDA accelerates research on psychedelic drugs after Trump order
FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Administration in…
RFK Jr. says he would support a possible ban on junk food TV ads
U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. gestures as he speaks during an event in the…
Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7 billion
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday.…
Trump nominates Erica Schwartz as CDC director
Rear Admiral Erica G. Schwartz. US Department of Health and Human Services President Donald Trump on Thursday nominated Erica Schwartz…
Revolution Medicines' pancreatic cancer drug daraxonrasib succeeds in trial
Medicines of the revolution'The pancreatic cancer drug was successful in a highly anticipated Phase 3 trial, nearly doubling the typical…
Novo Nordisk partners with OpenAI as hopes rise for AI drug discovery
Nordisk is partnering with OpenAI to “bring new and better treatment options to patients faster,” the Danish drugmaker said Tuesday.…